297 related articles for article (PubMed ID: 10955840)
21. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives.
Chung TW; Tsai YL; Hsieh JH; Tsai WJ
J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974
[TBL] [Abstract][Full Text] [Related]
22. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.
Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR
Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635
[TBL] [Abstract][Full Text] [Related]
23. Stabilization of Human Immunoglobulin G Encapsulated within Biodegradable Poly (Cyclohexane-1, 4-diyl Acetone Dimethylene Ketal) (PCADK)/ Poly (Lactic-co-Glycolic Acid) (PLGA) Blend Microspheres.
Wang C; Yu C; Liu J; Sun F; Teng L; Li Y
Protein Pept Lett; 2015; 22(11):963-71. PubMed ID: 26268563
[TBL] [Abstract][Full Text] [Related]
24. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
Murty SB; Goodman J; Thanoo BC; DeLuca PP
AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
[TBL] [Abstract][Full Text] [Related]
25. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
26. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
[TBL] [Abstract][Full Text] [Related]
29. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres.
Rosa GD; Iommelli R; La Rotonda MI; Miro A; Quaglia F
J Control Release; 2000 Nov; 69(2):283-95. PubMed ID: 11064135
[TBL] [Abstract][Full Text] [Related]
30. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
31. Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons.
Tan EY; Law JW; Wang CH; Lee AY
Pharm Res; 2007 Dec; 24(12):2297-308. PubMed ID: 17899323
[TBL] [Abstract][Full Text] [Related]
32. Stabilization of pH-induced degradation of porcine insulin in biodegradable polyester microspheres.
Shao PG; Bailey LC
Pharm Dev Technol; 1999; 4(4):633-42. PubMed ID: 10578518
[TBL] [Abstract][Full Text] [Related]
33. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
34. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable PLGA microspheres as a sustained release system for a new luteinizing hormone-releasing hormone (LHRH) antagonist.
Du L; Cheng J; Chi Q; Qie J; Liu Y; Mei X
Chem Pharm Bull (Tokyo); 2006 Sep; 54(9):1259-65. PubMed ID: 16946531
[TBL] [Abstract][Full Text] [Related]
36. Accelerated polymer biodegradation of risperidone poly(D, L-lactide-co-glycolide) microspheres.
Selmin F; Blasi P; DeLuca PP
AAPS PharmSciTech; 2012 Dec; 13(4):1465-72. PubMed ID: 23090111
[TBL] [Abstract][Full Text] [Related]
37. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
[TBL] [Abstract][Full Text] [Related]
38. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro].
Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L
Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137
[TBL] [Abstract][Full Text] [Related]
39. Alendronate PLGA microspheres with high loading efficiency for dental applications.
Nafea EH; El-Massik MA; El-Khordagui LK; Marei MK; Khalafallah NM
J Microencapsul; 2007 Sep; 24(6):525-38. PubMed ID: 17654173
[TBL] [Abstract][Full Text] [Related]
40. Acidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy.
Ding AG; Schwendeman SP
Pharm Res; 2008 Sep; 25(9):2041-52. PubMed ID: 18622692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
